NEW YORK, Feb. 22, 2018 -- Global Infection Surveillance Systems is designed to support decision making in infection prevention and control (IPC) programs by improving surveillance practices . Hospital-acquired infections (HAIs) has become serious concern globally. It occurs in at least 48 hours into a patient’s hospital stay that were neither present nor incubating at the time of patient admission. HAIs are critical safety concerns for patients, healthcare professionals and healthcare systems. Infection surveillance system has emerged as support to evidence-based prevention and control programs in order to reduce HAI prevalence.
Infection Surveillance Systems Market has shown tremendous growth from 2012 and expected to reach 1.09 billion by 2024 at CAGR of 15.65 % between 2015-24. Increasing occurrences of Hospital-acquired infections (HAIs) globally is main force driving Infection surveillance System Market. United States Infection surveillance System Market is expected to reach USD 600 million by 2024 holds almost 60% of market shares. Infection surveillance System is also emerging very rapidly in Europe, China, Japan, India and South Korea.
Get Free Sample: https://www.profsharemarketresearch.com/sample/infection-surveillance-systems-market-report-sample/
Infection Surveillance Systems on downside:
• Requires prolonged surveillance,
• Varied majorly in accordance to treatment.
• Challenging to implement in many low to middle-income countries (LMICs)
• Microbiology laboratory and IT infrastructure requires
• Patient records may be incomplete, inconsistent and hence unusable in Infection surveillance System.
Surgical site infections, which can occur up to thirty days post-operatively, may be difficult to conduct. These challenges may lead to non- or under-detection of HAI’s with resultant missed opportunities to institute the appropriate medical treatment. In LMICs prevalence of HAIs ranges from 5% to 70% among hospitalized patients, with surgical site infections being the most common. Highest HAI rates were found in intensive care unit (ICU), Neonatal ICU and Orthopaedics / burn unit.
Buy Report: https://www.profsharemarketresearch.com/buy/infection-surveillance-systems-market-report-buy-su/
Infection Surveillance Systems Market : Product Type
• Hardware
• Software
• Services
Infection Surveillance Systems Market : Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Infection surveillance System Market :
BD Medical
• Premier
• Wolters Kluwer
• Baxter International
• GOJO Industries
• Atlas Medical Software
• Deb Group
• Hygreen
• RL Solutions
• Truven Health Analytics
Contact Us:
Mia Cox,
Email- [email protected]
Tel- 1-877-797-7295
www.profsharemarketresearch.com


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



